Credit: Getty Images Until semaglutide, weight loss of 15% ... treatment of obesity: STEP 1, the largest trial, compared semaglutide and LI with placebo and LI over 68 weeks.

A trial exploring ... the two doses of semaglutide were comparable, while around a third of patients treated with 7.2mg achieved more than 25% weight loss. "Results from STEP UP further strengthen ...

Over 72 weeks, patients taking ... Novo Nordisk's STEP trial programme for once-weekly GLP-1 agonist Wegovy (semaglutide) revealed a reduction in body weight of around 12%, suggesting greater ...

A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...

The FDA has accepted for review the New Drug Application for a 25mg oral formulation of semaglutide for chronic weight management.

Interest in weight-loss products continues to surge as calls come for a faster rollout of treatments on the NHS. Research by ...

Popular weight-loss drugs like Ozempic and Wegovy are helping millions worldwide shed unwanted pounds, but it appears they’ve also been eating away at WeightWatcher’s profits. WW International ...

A private couple purchased the property, which included five acres of land and a neglected but large home, in September 2021, just weeks before Josh’s trial began. The house, which was initially ...

Veru Inc. continues to navigate its financial challenges, reporting a net loss of $7.9 million in Q2 2025 ... investor interest driven by the EPS beat and positive clinical trial outcomes. Veru Inc.

Veru Inc. continues to navigate its financial challenges, reporting a net loss of $7.9 million in Q2 ... by the EPS beat and positive clinical trial outcomes. Veru Inc. anticipates unblinded ...